ArticleCancers2022

Strong Humoral but Not Cellular Immune Responses against SARS-CoV-2 in Individuals with Oncohematological Disease Who Were Treated with Rituximab before Receiving a Vaccine Booster.

Montserrat Torres et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.